Ishita Drugs Industries Ltd vs Natural Capsules Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Ishita Drugs & Industries Ltd is ₹ 81.93 as of 06 May 15:30 . The P/E Ratio of Ishita Drugs & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Natural Capsules Ltd changed from 9.7 on March 2021 to 307 on March 2025 . This represents a CAGR of 99.56% over 5 years The Market Cap of Ishita Drugs & Industries Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Natural Capsules Ltd changed from ₹ 67.03 crore on March 2021 to ₹ 190.48 crore on March 2025 . This represents a CAGR of 23.23% over 5 years The revenue of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Natural Capsules Ltd for the Dec '25 is ₹ 38.19 crore as compare to the Sep '25 revenue of ₹ 45.96 crore. This represent the decline of -16.91% The ebitda of Ishita Drugs & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Natural Capsules Ltd for the Dec '25 is ₹ -1.88 crore as compare to the Sep '25 ebitda of ₹ -0.72 crore. This represent the growth of 161.11% The net profit of Ishita Drugs & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Natural Capsules Ltd changed from ₹ 0.6 crore to ₹ -7.12 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Ishita Drugs & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Natural Capsules Ltd changed from 8.96 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal.
The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
The company supplies its products to leading pharmaceutical companies of India.
The products are also being exported to various countries across the world.
The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.

About Natural Capsules Ltd

Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore.
The Company is one of the leading manufacturers of hard capsule shells in India.
The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. Company expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs.
The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.

FAQs for the comparison of Ishita Drugs & Industries Ltd and Natural Capsules Ltd

Which company has a larger market capitalization, Ishita Drugs & Industries Ltd or Natural Capsules Ltd?

Market cap of Ishita Drugs & Industries Ltd is 24 Cr while Market cap of Natural Capsules Ltd is 160 Cr

What are the key factors driving the stock performance of Ishita Drugs & Industries Ltd and Natural Capsules Ltd?

The stock performance of Ishita Drugs & Industries Ltd and Natural Capsules Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ishita Drugs & Industries Ltd and Natural Capsules Ltd?

As of May 6, 2026, the Ishita Drugs & Industries Ltd stock price is INR ₹81.93. On the other hand, Natural Capsules Ltd stock price is INR ₹154.15.

How do dividend payouts of Ishita Drugs & Industries Ltd and Natural Capsules Ltd compare?

To compare the dividend payouts of Ishita Drugs & Industries Ltd and Natural Capsules Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.